Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?

We recently compiled a list of the 10 Best Innovative Healthcare Stocks to Buy Now. Alcon Inc. (NYSE:ALC) is one of the best healthcare stocks on our list.

TheFly reported on July 2 that Argus lowered its price target on ALC to $85 from $90 while maintaining a Buy rating on the shares. The firm noted that ALC’s stock is trading significantly below its historical highs and averages, creating a potential valuation opportunity. The company’s improved earnings outlook, with management forecasting 10%-13% growth in 2026 compared with flat performance in 2025, is supported by a strong late-stage product pipeline. Argus highlighted upcoming regulatory submissions expected in 2027 and 2028 as a factor supporting expectations for continued long-term growth.

Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?

In other news, on July 6, Alcon Inc. (NYSE:ALC) and RxSight (RXST) announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). The partnership will combine RxSight’s post-operative light-adjustable technology with ALC’s PCIOL optical designs to create a platform aimed at improving vision outcomes for cataract patients. Under the agreement, RxSight will receive a $60 million upfront payment to support development activities and may earn up to an additional $140 million through development and regulatory milestones. ALC will oversee global commercialization efforts, while RxSight will manage development and manufacturing responsibilities and receive royalties from product sales.

Alcon Inc. (NYSE:ALC) is a global leader in eye care, developing advanced surgical devices, intraocular lenses (IOLs), and vision care products across 140+ countries. The company focuses on innovation through digital and robotic surgery, next-generation IOL platforms like Clareon, and virtual reality training tools to improve eye care outcomes.

While we acknowledge the risk and potential of ALC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ALC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1